{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:07:48Z","timestamp":1791990468963,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Adolfo Lutz Institute, Secretary of Health of the State of S\u00e3o Paulo"},{"name":"The National Council for Scientific and Technological Development\/CNPq","award":["304211\/2014-1"],"award-info":[{"award-number":["304211\/2014-1"]}]},{"name":"The National Council for Scientific and Technological Development\/CNPq","award":["306096\/2010-2"],"award-info":[{"award-number":["306096\/2010-2"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vaccine.2018.04.010","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T18:43:27Z","timestamp":1523299407000},"page":"2559-2566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Distribution of invasive Streptococcus pneumoniae serotypes before and 5\u202fyears after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil"],"prefix":"10.1016","volume":"36","author":[{"given":"Maria-Cristina C.","family":"Brandileone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanta C.G.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Minamisava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5911-5158","authenticated-orcid":false,"given":"Ana-Lucia","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.04.010_b0005","unstructured":"GBD 2015 LRI Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tractinfectionsin 195 countries: a systematic analysis for the GlobalBurdenofDiseaseStudy 2015. Lancet Infect Dis 2017; 17(11): p. 1133\u201361."},{"issue":"9693","key":"10.1016\/j.vaccine.2018.04.010_b0010","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.010_b0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12325-013-0007-6","article-title":"The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review","volume":"30","author":"Myint","year":"2013","journal-title":"Adv Ther"},{"issue":"18","key":"10.1016\/j.vaccine.2018.04.010_b0020","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.04.010_b0025","unstructured":"The Strategic Advisory Group of Experts on Immunization (SAGE) Working Group. Pneumococcal Conjugate Vaccine (PCV) Review of Impact Evidence (PRIME), Summary of Findings from Systematic Review, October 2017, http:\/\/www.who.int\/immunization\/sage\/meetings\/2017\/october\/3_FULL_PRIME_REPORT_2017Sep26.pdf?ua=1Olivia."},{"key":"10.1016\/j.vaccine.2018.04.010_b0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","article-title":"Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects","volume":"32","author":"Davis","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.010_b0035","unstructured":"Brazil. Ministry of health. National immunization program. [Technical Inform on pneumococcal 10-valent vaccine (conjugate)]. In: Ministry of Health [Internet]. 2010 [cited 20.06.17]. http:\/\/www.sgc.goias.gov.br\/upload\/links\/arq_723_infotec.pdf."},{"key":"10.1016\/j.vaccine.2018.04.010_b0040","unstructured":"Brazil. Information system of the national immunization program (SI-PNI),http:\/\/pni.datasus.gov.br\/inf_estatistica_cobertura.asp [accessed 17.02.07]."},{"issue":"6","key":"10.1016\/j.vaccine.2018.04.010_b0045","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-2600(14)70060-8","article-title":"Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study","volume":"2","author":"Domingues","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.010_b0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/21645515.2015.1117713","article-title":"Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: a time-series analysis","volume":"12","author":"Andrade","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.vaccine.2018.04.010_b0055","doi-asserted-by":"crossref","first-page":"e1001517","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites","volume":"10","author":"Feikin","year":"2013","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.vaccine.2018.04.010_b0060","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S2213-2600(17)30110-8","article-title":"Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study","volume":"5","author":"Savulescu","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.vaccine.2018.04.010_b0065","doi-asserted-by":"crossref","first-page":"e111129","DOI":"10.1371\/journal.pone.0111129","article-title":"Serotypes and genotypes of invasive Streptococcus pneumoniae before and after PCV10 implementation in southern Brazil","volume":"9","author":"Caier\u00e3o","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.010_b0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bjid.2015.10.005","article-title":"Clinical and bacteriological characteristics of invasive pneumococcal disease after pneumococcal 10-valent conjugate vaccine implementation in Salvador, Brazil","volume":"20","author":"Leite","year":"2016","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.010_b0075","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1016\/j.vaccine.2013.05.042","article-title":"Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation","volume":"31","author":"dos Santos","year":"2013","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2018.04.010_b0080","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1016\/j.vaccine.2016.09.027","article-title":"Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in S\u00e3o Paulo, Brazil","volume":"34","author":"Brandileone","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.010_b0085","unstructured":"World Health Organization and Centers for Disease Control and Prevention. Laboratory methods for diagnosis of meningitis caused byNeissaria meningitidis,Streptococcus pneumoniae, andHaemophilus influenzae, WHO manual, WHO\/IVB.11.09. 2nd ed., Geneva; 2011, https:\/\/www.cdc.gov\/meningitis\/lab-manual\/full-manual.pdf."},{"issue":"5","key":"10.1016\/j.vaccine.2018.04.010_b0090","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1128\/JCM.02243-09","article-title":"Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes","volume":"48","author":"da Gloria","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.04.010_b0095","unstructured":"Centers for Diseases Control and Prevention, https:\/\/www.cdc.gov\/streplab\/pcr.html [accessed 17.01.16]."},{"issue":"8","key":"10.1016\/j.vaccine.2018.04.010_b0100","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1086\/374396","article-title":"Appropriateness of a pneumococcal conjugate vaccine in Brazil: potential impact of age and clinical diagnosis, with emphasis on meningitis","volume":"187","author":"Brandileone","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.010_b0105","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1099\/jmm.0.47612-0","article-title":"Molecular assessment of invasive Streptococcus pneumoniae serotype 1 in Brazil: evidence of clonal replacement","volume":"57","author":"Chiou","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2018.04.010_b0110","first-page":"495","article-title":"Prevalence of serotypes and antimicrobial resistance of invasive strains of pneumococcus in children: analysis of 9 years","volume":"85","author":"Mantese","year":"2009","journal-title":"J Pediatr (Rio J)"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.010_b0115","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1128\/JCM.00058-13","article-title":"Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011","volume":"51","author":"Hulten","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.04.010_b0120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2334-13-70","article-title":"Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children","volume":"13","author":"van der Linden","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.010_b0125","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2018.04.010_b0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4067\/S0716-10182016000300009","article-title":"Statement of the advisory immunization committee of the Chilean society of infectious diseases on the emergence of serotype 19A pneumococcal infection and the use of pneumococcal conjugated vaccine in Chilean children","volume":"33","author":"Potin","year":"2016","journal-title":"Rev Chilena Infectol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.04.010_b0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jac\/dkp210","article-title":"Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain","volume":"64","author":"Ardanuy","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.vaccine.2018.04.010_b0140","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/jir052","article-title":"Shifting genetic structure of invasive serotype 19A pneumococci in the United States","volume":"203","author":"Beall","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.010_b0145","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.vaccine.2013.12.024","article-title":"Characterization of Streptococcus pneumoniae invasive serotype 19A isolates recovered in Colombia","volume":"32","author":"Ramos","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.010_b0150","unstructured":"Almeida SCG, Cassiolato AP, Amorim CS, Guerra MLLS, Bokermann S, Prado LS et al. Increase in 19A and 6C serotypes after 5 years of PCV10 routine immunization in Brazil. In: 10th international symposium on pneumococci & pneumococcal diseases, 2016; Glasgow, Scotland."},{"key":"10.1016\/j.vaccine.2018.04.010_b0155","unstructured":"Cassiolato AP, Almeida SCG, Guerra MLLS, Bokermann S, Prado, LS, Andrade ALSS, et al. Changes in invasive Streptococcus pneumoniae serotype 19A after introduction of 10-valentt pneumococcal conjugate vaccine (PCV10) in Brazil. In: 9th world congress of the world society for pediatric infectious diseases (WSPID), 2015; Rio de Janeiro, Brazil."},{"key":"10.1016\/j.vaccine.2018.04.010_b0160","doi-asserted-by":"crossref","first-page":"e0120290","DOI":"10.1371\/journal.pone.0120290","article-title":"Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children-a population-based study","volume":"10","author":"Jokinen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.04.010_b0165","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.vaccine.2015.04.005","article-title":"Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada","volume":"33","author":"Deceunincka","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.010_b0170","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.vaccine.2013.11.028","article-title":"Impact of 2 + 1 pneumococcal conjugate vaccine program in the province of Quebec, Canada","volume":"32","author":"De Wals","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.010_b0175","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1128\/JCM.02207-10","article-title":"Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children\u2019s Hospitals in the United States from 1993 to 2009","volume":"49","author":"Green","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.04.010_b0180","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1086\/657070","article-title":"Pre- and post-conjugate vaccine epidemiology of pneumococcal serotype 6C invasive disease and carriage within Navajo and White Mountain Apache communities","volume":"51","author":"Millar","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2018.04.010_b0185","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/jac\/dkr193","article-title":"Trends of invasive serotype 6C pneumococci in Spain: emergence of a new lineage","volume":"6","author":"Rolo","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"21","key":"10.1016\/j.vaccine.2018.04.010_b0190","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2017.04.019","article-title":"Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: the emergence of multidrug resistant serotype 6C","volume":"35","author":"Neves","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.04.010_b0195","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1183\/09031936.00050413","article-title":"Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes","volume":"43","author":"Burgos","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2018.04.010_b0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/thx.2009.123612","article-title":"Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes","volume":"65","author":"Garcia-Vidal","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2018.04.010_b0205","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1086\/593339","article-title":"Differential effects of pneumococcal vaccines against serotypes 6A and 6C","volume":"198","author":"Park","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.04.010_b0210","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.04.010_b0215","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/cid\/cix685","article-title":"Comparison of the impact of pneumococcal conjugate vaccine 10 or pneumococcal conjugate vaccine 13 on invasive pneumococcal disease in equivalent populations","volume":"65","author":"Naucler","year":"2017","journal-title":"CID"},{"key":"10.1016\/j.vaccine.2018.04.010_b0220","unstructured":"Brazil, https:\/\/pebmed.com.br\/novo-calendario-nacional-de-vacinacao-do-ministerio-da-saude-para-2017\/."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18304791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18304791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T11:53:09Z","timestamp":1534938789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18304791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":44,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0264410X18304791"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distribution of invasive Streptococcus pneumoniae serotypes before and 5\u202fyears after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}